Strategic Wealth Partners’s Tandem Diabetes Care TNDM Stock Holding History

Strategic Wealth Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,508	Closed	-$1.34M	–	283
2022 Q1	$1.34M	Sell	11,508 -674	-6%	-$78.7K	0.26%	111
2021 Q4	$1.83M	Buy	12,182 +394	+3%	+$53.2K	0.35%	92
2021 Q3	$1.41M	Buy	11,788 +3,806	+48%	+$419K	0.41%	65
2021 Q2	$777K	Buy	7,982 +564	+8%	+$50.3K	0.25%	100
2021 Q1	$655K	Buy	7,418 +1,779	+32%	+$165K	0.26%	96
2020 Q4	$540K	Buy	5,639 +3,676	+187%	+$379K	0.23%	110
2020 Q3	$223K	Sell	1,963 -740	-27%	-$77.7K	0.11%	141
2020 Q2	$267K	Buy	+2,703	New	+$216K	0.14%	116
2019 Q4	–	Sell	-1,000	Closed	-$55	–	470
2019 Q3	$55	Hold	1,000	–	–	﹤0.01%	295
2019 Q2	$64K	Hold	1,000	–	–	0.03%	211
2019 Q1	$60K	Buy	+1,000	New	+$52.5K	0.03%	216

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Strategic Wealth Partners's TNDM Position: Q2 2022 in Review

Strategic Wealth Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 11,508 shares — an estimated $1.34M sold.

Strategic Wealth Partners first reported a position in TNDM in Q1 2019 and held it in 11 quarters. The position peaked at $1.83M in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Strategic Wealth Partners reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Strategic Wealth Partners sold 11,508 Tandem Diabetes Care shares in Q2 2022, an estimated $1.34M.
Strategic Wealth Partners first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 11 quarters.
Strategic Wealth Partners's Tandem Diabetes Care position peaked at $1.83M in Q4 2021.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Strategic Wealth Partners's 13F filing for Q2 2022, filed 22 Aug 2022.